January 28, 2020
|SNMMI President Vasken Dilsizian and patient advocate Josh Mailman speak at the NRC Commissioners Meeting. From left: Commissioner Jeff Baran, Commissioner Annie Caputo, ASTRO President Thomas Eichler, Mailman, Chairman Kristine L. Svinicki, Dilsizian, Commissioner David A. Wright.|
|Vasken Dilsizian, MD
Rockville, MD—Today SNMMI President Vasken Dilsizian, MD, and patient advocate Josh Mailman participated in a Nuclear Regulatory Commission (NRC) briefing at the NRC Headquarters in Rockville, Maryland, to provide their perspectives on recent NRC staff initiatives related to medical uses of radioactive materials.
The meeting was broken into two panels: one for NRC staff and one for stakeholders from the medical use of radioactive materials community. Each of the five presenters from their respected group gave an 8-minute presentation from the perspective of their individual expertise. Following the groups’ presentations, the NRC commissioners were granted 40 minutes to ask the panelists questions.
Dr. Dilsizian was one of two society presidents who were asked to participate in the panel. During his presentation, he highlighted the importance of appropriate training and experience requirements for authorized users, addressed concerns of patient safety and patient release materials, and spoke about the future of this field.
Mr. Josh Mailman was the only patient to sit on the board. During his presentation, he was able to provide unique perspective from an “end user” of these radioactive materials. Mr. Mailman used his presentation to educate commissioners about neuroendocrine tumors and his patient organization, providing perspective on the process patients go through for these procedures, and also spoke about the importance of training and experience requirements for authorized users.